h.varga

TL2 · Graz

Contributes reviews on supplier material. Based in Graz.

Joined 6 January 2025 · last posted 7d

92 posts, newest first. Showing up to 150.

What to bring: records that a clinician can actually use Replied, post #10 · Clinical › Prescriber conversations · 21 Jul 2026 · 31 likes Coming back to post #8, because the follow-up matters more than the original answer. Discussing off-label dosing: if you want to dose differently than the label…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #34 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 1 like Before the thread moves on from Detection wavelength — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n…
A site rotation scheme that is easy enough to actually follow Replied, post #112 · Practice › Administration · 12 Jul 2026 · 6 likes Coming back to post #108, because the follow-up matters more than the original answer. If you have to inject at a different time of day than usual, that is a much…
Aggregate verification data across the directory, with caveats Replied, post #40 · Sourcing › Independent verification · 11 Jul 2026 · 2 likes The bit of aggregate verification data that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and…
How much context is too much context in a first post? Replied, post #2 · Start Here › How to Ask · 3 Jul 2026 · 23 likes Taking the opening post at face value and following it one step further. Quantities without units are the single commonest reason a question sits unanswered. "Two and a…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #48 · Analytics › Home & field testing · 3 Jul 2026 · 2 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Started this topic · Analytics › HPLC & UHPLC · 28 Jun 2026 · 36 likes Detection wavelength and why 214 nm and 280 nm disagree — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with…
Does dual agonism explain the effect size, or is it dose? Replied, post #63 · Compounds › Tirzepatide · 27 Jun 2026 · 0 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #74 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 9 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #30 · Compounds › Secretagogues & GH axis · 25 Jun 2026 · 25 likes Helpful, and easy to find again, which is half of what a good reply is.
A site rotation scheme that is easy enough to actually follow Replied, post #92 · Practice › Administration · 19 Jun 2026 · 21 likes Post #91 is the version of this I will quote in future. One addition. The bit of site rotation scheme that nobody enjoys is that the answer changes depending on what…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #40 · Start Here › How to Ask · 14 Jun 2026 · 1 like Marking my place. If it changes for me I will come back and say so.
How this community escalates rather than diagnoses — does this still hold? Replied, post #4 · marked as the solution · Safety › Adverse events · 13 Jun 2026 · 7 likes Allergic-type reactions with breathing difficulty or swelling are an emergency rather than a topic, and this subcategory says so in its own guidance. Not the whole…
Follow-up: Sleep quality changes during weight loss Replied, post #44 · Wellbeing › Sleep · 13 Jun 2026 · 25 likes Caffeine and alcohol both affect sleep architecture and both change during a period of reduced intake without anybody deciding to change them.
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #69 · Sourcing › Vendor reports · 19 May 2026 · 33 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
Pancreatitis history and the risk calculus Replied, post #9 · Safety › Contraindications · 10 May 2026 · 0 likes Narrowing post #8, because the general version has more than one answer. A request rather than an answer: could whoever has the primary source for pancreatitis history…
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #13 · Sourcing › Vendor reports · 29 Apr 2026 · 0 likes Where you have no independent result, a documentation report is still worth filing: what the certificate contained, what it omitted, and how fast a request was…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #20 · Practice › Administration · 27 Apr 2026 · 1 like Where I have landed on Pinch, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it…
Managing an unplanned gap in supply Replied, post #108 · Access › Shortages · 23 Apr 2026 · 15 likes An update on my earlier managing an unplanned gap post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Request declined, with reasoning — what changed since Replied, post #32 · Meta › Feature requests · 22 Apr 2026 · 0 likes Building on post #31 rather than restating it. Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #37 · Compounds › Repair & healing peptides · 14 Apr 2026 · 23 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #26 · Evidence › Preprints · 8 Apr 2026 · 0 likes The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting. This is where my knowledge…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #39 · Practice › Administration · 2 Apr 2026 · 13 likes My understanding of Pinch is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Search filters: what is missing Replied, post #42 · Meta › Site feedback · 1 Apr 2026 · 0 likes Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow). I keep a log of…
Grapefruit: why this class is not the class that cares Replied, post #86 · Practice › Interactions · 27 Mar 2026 · 2 likes That is a fair summary of where the discussion has got to.
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #40 · Practice › Administration · 20 Mar 2026 · 24 likes Post #36 put the caveat in the right place and I want to underline it. Adding a reference point for injection discomfort. Mine is a single case, collected without…
The "under review" status pill and when a moderator applies it Replied, post #28 · Evidence › Preprints · 20 Mar 2026 · 15 likes Worth separating two things that post #25 runs together. Author track record is a weak signal and it is a signal. A group that has published carefully for years is a…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #27 · Research Methods › N-of-1 designs · 2 Mar 2026 · 4 likes Adding the measurement that post #24 says would settle it. Reporting the whole series rather than the interesting segment is the discipline that makes personal data…
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #2 · Practice › Dosing & titration · 1 Mar 2026 · 33 likes Building on the opening post rather than restating it. A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #127 · Access › International · 24 Feb 2026 · 15 likes My understanding of Language barriers in accessing is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
Second pass at: Metformin co-administration and additive GI effects Replied, post #54 · Practice › Interactions · 22 Feb 2026 · 2 likes The confident answers on Metformin co-administration and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #17 · Practice › Dosing & titration · 15 Feb 2026 · 7 likes Post #14 is right about the mechanism and I think understates the practical bit. Reaching a dose and staying there for a year: the question of whether a stable dose…
Prescription portability between countries — the long version Started this topic · Access › International · 13 Feb 2026 · 20 likes On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. A narrow question about Prescription…
Research-use-only status: what it means legally and practically Replied, post #4 · Compounds › Other compounds · 13 Feb 2026 · 2 likes If you are new and reading this thread for the answer to research-use-only status: the answer is conditional, the conditions are in the third reply, and the rest of the…
Reading a home test result without over-claiming — what changed since Replied, post #3 · Analytics › Home & field testing · 8 Feb 2026 · 0 likes The most useful home practice is not a test at all: photograph the vial, the cake, the label and the document on arrival. It costs nothing and it is the evidence you…
About the COA interpretation category Replied, post #3 · Analytics › COA interpretation · 6 Feb 2026 · 8 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Revisiting: Absolute versus relative contraindications Replied, post #19 · Safety › Contraindications · 4 Feb 2026 · 4 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
Interpreting a result that disagrees with the supplier's certificate Replied, post #97 · Sourcing › Independent verification · 27 Jan 2026 · 0 likes Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot.
Heterogeneity as information rather than as a nuisance Replied, post #74 · Evidence › Meta-analyses · 24 Jan 2026 · 0 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
Prescription requirements and telehealth models Replied, post #90 · Sourcing › Regulatory · 25 Dec 2025 · 1 like Post #87 is the version of this I will quote in future. One addition. Scheduling and prescription status are separate questions and the answer to one does not imply the…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #30 · Research Methods › N-of-1 designs · 24 Dec 2025 · 0 likes A rolling mean over several days is far more informative than any single reading for anything that varies day to day, which is nearly everything.
Robustness: the parameters worth deliberately varying Replied, post #14 · Analytics › Method validation · 22 Nov 2025 · 10 likes Two things can be true about robustness at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
Pen dose counters: what a click does and does not guarantee Replied, post #100 · Devices › Pens & autoinjectors · 19 Nov 2025 · 28 likes Useful. I have added it to my own notes with the date on it.
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #96 · Compounds › Tirzepatide · 18 Nov 2025 · 1 like Worth separating two things that post #92 runs together. SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose…
Managing an unplanned gap in supply — what changed since Replied, post #110 · Access › Shortages · 8 Nov 2025 · 33 likes Bookmarking this. I will come back when I have something worth adding.
A 40-week log with the measurement method stated Replied, post #20 · Outcomes › Progress reports · 16 Oct 2025 · 11 likes Reading rather than answering, but this is the post I would point somebody at.
Can a home kit substitute for a laboratory report? A careful no Replied, post #31 · Analytics › Home & field testing · 15 Oct 2025 · 30 likes Post #29 and I disagree about the size of the effect, not about the direction. Precision of home tests: most consumer-accessible devices are not precise to the level…
Insurance and replacement policies, compared — the long version Replied, post #22 · Sourcing › Logistics · 2 Oct 2025 · 29 likes A request rather than an answer: could whoever has the primary source for Insurance and replacement policies post it? I have seen the claim three times this month and…
Follow-up: Why appetite effects are mostly central Replied, post #54 · Pharmacology › Receptor biology · 30 Sep 2025 · 23 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #23 · Practice › Interactions · 27 Sep 2025 · 13 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #131 · Data & Tools › Calculators · 27 Sep 2025 · 14 likes The version of titration planner refuses that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Why catalogue breadth is not evidence of anything — what changed since Replied, post #52 · Compounds › Other compounds · 23 Sep 2025 · 0 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #99 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes Post #96 is right about the mechanism and I think understates the practical bit. How to contribute: if you have longitudinal data you want to add, the format is simple:…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #31 · Practice › Side effects · 2 Sep 2025 · 7 likes Understood, and I withdraw the assumption I opened with.
What this community means by "a source", in practical terms Replied, post #87 · Start Here › Welcome · 26 Aug 2025 · 10 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #31 · Devices › Pens & autoinjectors · 19 Aug 2025 · 1 like A pen that has been dropped may not be visibly damaged and may not deliver accurately afterwards. Manufacturers say to replace rather than to test, and there is no test…
When a preprint is the best available evidence and we say so Replied, post #70 · Evidence › Preprints · 18 Aug 2025 · 0 likes Post #68 put the caveat in the right place and I want to underline it. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint].…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #23 · Evidence › Journal club · 16 Aug 2025 · 5 likes Speaking only to orforglipron phase 2 as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests,…
A field-by-field walk through a certificate of analysis Replied, post #142 · Analytics › COA interpretation · 18 Jul 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #41 · Data & Tools › Calculators · 3 Jul 2025 · 6 likes Noted, and thank you for writing it out rather than summarising it.
Why the timeline is on the right and not the left Replied, post #36 · Meta › Site feedback · 3 Jul 2025 · 9 likes The arithmetic in post #35 is right; the assumption feeding it is the part to check. Performance: if pages are slow to load, timeouts occur, or the site is…
What a 2 ppm match establishes, and what it does not Replied, post #26 · Analytics › Mass spectrometry · 17 Jun 2025 · 18 likes Coming back to post #24, because the follow-up matters more than the original answer. Resolution: "high resolution" commonly means Posted with less confidence than the…
Coming back to: An 18-month record including the parts that went badly Replied, post #66 · Outcomes › Progress reports · 15 Jun 2025 · 0 likes Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change once loss stops. Adding a source would improve this…
Half-life, steady state, and accumulation worked through Replied, post #20 · Pharmacology › Pharmacokinetics · 25 May 2025 · 7 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
Second pass at: Designing a personal experiment that could change your mind Replied, post #42 · Research Methods › N-of-1 designs · 22 May 2025 · 2 likes Post #39 is the version of this I will quote in future. One addition. Blinding yourself is harder than it sounds and is not impossible. Somebody else preparing labelled…
Travel coolers and how long they really hold — the long version Replied, post #4 · Devices › Cold chain · 19 May 2025 · 0 likes Post #3 answers the question as asked. The question underneath it is different. I would rather this thread reach "we do not know" about Travel coolers than reach a…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #109 · Sourcing › Independent verification · 17 May 2025 · 24 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. I have seen…
Follow-up: Documentation that appears only after payment Replied, post #51 · Sourcing › Red flags · 6 May 2025 · 20 likes The bit of Documentation that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #105 · Compounds › Semaglutide · 5 May 2025 · 3 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
Relative retention time as a better inter-laboratory comparator Replied, post #4 · Analytics › Method validation · 24 Apr 2025 · 1 like Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
A certificate whose chromatogram axes do not match its stated method Replied, post #9 · Sourcing › Red flags · 20 Apr 2025 · 0 likes Checked the certificate whose chromatogram axes claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #46 · Practice › Interactions · 13 Apr 2025 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #10 · Clinical › Comorbidities · 29 Mar 2025 · 14 likes Since Cardiovascular risk keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #125 · Access › International · 26 Mar 2025 · 23 likes I would call the community position on Cross-border purchase within likely rather than established, and I would be comfortable defending that hedge.
Counter-ion form: the field almost nobody reports — one year on Replied, post #117 · Analytics › COA interpretation · 24 Mar 2025 · 4 likes What I would check first on Counter-ion form is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #112 · Sourcing › Regulatory · 24 Mar 2025 · 0 likes A definition problem is doing most of the work in this Research-use-only labelling discussion. Once the term is pinned down I suspect the disagreement mostly goes away…
Follow-up: What other technical communities get right that we do not Replied, post #38 · Lounge › Off topic · 13 Mar 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
Validating a method you did not develop — does this still hold? Replied, post #104 · Analytics › Method validation · 12 Mar 2025 · 1 like My understanding of Validating a method is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Consistent declarations and why they matter more than clever ones Replied, post #96 · Sourcing › Logistics · 27 Feb 2025 · 0 likes Speaking only to consistent declarations as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests,…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #51 · Devices › Cold chain · 13 Feb 2025 · 15 likes Confirming post #49 from a second method, which matters more than confirming it from a second person. Nobody has said the unglamorous part of Domestic fridge…
Identical chromatograms across two different lots Replied, post #76 · Sourcing › Red flags · 14 Jan 2025 · 0 likes On identical chromatograms I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #21 · Practice › Reconstitution · 14 Jan 2025 · 4 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
When to suspect the method rather than the sample Replied, post #63 · Analytics › Method validation · 9 Jan 2025 · 3 likes Post #62 answers the question as asked. The question underneath it is different. Precision and repeatability: within-run and between-run variability of the method.…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #155 · Compounds › Oral incretins · 29 Dec 2024 · 17 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
The topic list is dense — is that deliberate? Replied, post #62 · Meta › Site feedback · 5 Dec 2024 · 6 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
Why "any advice?" is the least effective ending for a post Replied, post #102 · Start Here › How to Ask · 3 Dec 2024 · 10 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
Why "any advice?" is the least effective ending for a post Replied, post #20 · Start Here › How to Ask · 9 Nov 2024 · 0 likes Post #18 describes the usual case. This is about the unusual one. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post,…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #16 · Meta › Wiki maintenance · 24 Oct 2024 · 0 likes Summarising the revision dispute resolved thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #108 · Clinical › Bloodwork · 14 Oct 2024 · 26 likes I had written a reply contradicting post #104 and deleted it. Here is what survived. Glycaemic markers integrate over different periods. A point glucose and a…
Guidelines revision: what changed and why Replied, post #44 · Meta › Announcements · 26 Jul 2024 · 0 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. This is the sort of thing that ought to be settled and…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #52 · Practice › Dosing & titration · 8 Jul 2024 · 0 likes The thing about Splitting a weekly dose that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Second pass at: Journal club: LEADER as the historical anchor Replied, post #6 · Evidence › Journal club · 7 Jul 2024 · 18 likes Two people in this thread mean different things by LEADER and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…